336 results
Page 15 of 17
6-K
g4hk8u7shzg
25 Jan 11
Teva Enters into $1.5 Billion Syndicated Credit Facility
12:00am
6-K
s9gul2a9i5wxsspba93e
25 Jan 11
Teva Receives Fda Action Letter for Generic Lovenox?
12:00am
6-K
p3i8asc 27
11 Jan 11
Teva Calls 1.75% Convertible Debentures Due 2026 for Redemption
12:00am
6-K
yssaq6b3dj5gpua gg6
10 Jan 11
Teva Provides Update on Venlafaxine HCL Er
12:00am
6-K
kbiry 2ht
5 Jan 11
Teva Completes Acquisition of Theramex
12:00am
6-K
ihsbyhod tjlw3cx
23 Dec 10
Fda Issues Complete Response Letter for Lower-volume Glatiramer Acetate Snda
12:00am
6-K
dx8y2i
23 Dec 10
Teva and Takeda Settle Generic Actos? and Actoplus Met? Litigation
12:00am
6-K
zdn7ey73ib
14 Dec 10
Teva Files Citizen Petition Surrounding Purported Generic Version of Copaxone?
12:00am
6-K
kqy9 c97g3vb4olhwy3q
9 Dec 10
Teva Announces Successful Results of Phase III Study with Oral Laquinimod for Multiple Sclerosis
12:00am
6-K
3gq41
6 Dec 10
Teva Announces $1 Billion Share Repurchase Program
12:00am
6-K
w5ach38
1 Dec 10
Teva Announces $1 Billion Share Repurchase Program
12:00am
6-K
geegclc4k5egp
5 Nov 10
Teva Presents Respiratory Growth Strategy
12:00am
6-K
39xsoyudd5 4ix4m6
2 Nov 10
Current report (foreign)
12:00am
6-K
lo885hre6hjc
2 Nov 10
Teva Pharmaceutical Industries Limited - 6-K
12:00am
6-K
40witu4mxh up
28 Oct 10
Teva to Acquire Theramex, Merck Kgaa???s European Based Women???s Health Business
12:00am
6-K
6ur spnm5
19 Oct 10
Early Initiation of Treatment with Copaxone? Provides Greater Effects In Delaying Conversion to Clinically Definite MS
12:00am
6-K
l8kj3oqjf3g
19 Oct 10
Early Initiation of Treatment with Copaxone? Provides Greater Effects In Delaying Conversion to Clinically Definite MS
12:00am
6-K
bgf kcmhz
18 Oct 10
New Data Evaluating Laquinimod for the Treatment of Multiple Sclerosis Demonstrate Neuroprotective Effects
12:00am
6-K
stcd7 u3gkgh5grbg
6 Oct 10
Teva to Present New Data on Copaxone? and Laquinimod at the 26TH Annual Ectrims Congress
12:00am
6-K
vbkc31u3f mv
21 Sep 10
Oral Laquinimod Demonstrated Sustained Efficacy and Safety In Patients with Multiple Sclerosis
12:00am